Jack Cuzick
The Lancet · 2002–2020
A researcher in the Science corpus: 30 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Whom Jack Cuzick trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jack Cuzick overall
Papers from Jack Cuzick's perspective
Ordered by how strongly the researchers Jack Cuzick trusts endorse each paper. Same corpus, a different order for every researcher.
- Expert Commentary. (Histopathology)
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
- Aromatase inhibitors in breast cancer. (New England Journal of Medicine)
- Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. (Journal of Clinical Oncology)
- A new design for randomized clinical trials.
- Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in a Randomized Trial of Chemotherapy for Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer (The Lancet Oncology)
- Practical statistics for medical research
- Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer. (Journal of the National Cancer Institute)
- Validation of Tissue Microarray Technology in Breast Carcinoma (Laboratory Investigation)
- Proliferation marker Ki-67 in early breast cancer. (Journal of Clinical Oncology)
Their papers
- Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. (2011) — 1,714 citations
- Estimating the effect of treatment in a proportional hazards model in the presence of non‐compliance and contamination (2007) — 71 citations
- Key steps for effective breast cancer prevention (2020) — 683 citations
- De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (2018) — 862 citations
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (2018) — 913 citations
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. (2015) — 628 citations
- A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. (2015) — 1,402 citations
- Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. (2013) — 624 citations
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes for recurrence and death from prostate cancer: A retrospective study in two cohorts (2011) — 748 citations
- Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. (2011) — 724 citations
- The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomised trial in young overweight women (2010) — 752 citations
- Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. (2010) — 713 citations
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. (2010) — 1,542 citations
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. (2010) — 923 citations
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. (2010) — 1,669 citations
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older (2009) — 684 citations
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. (2009) — 707 citations
- Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study (2008) — 684 citations
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. (2008) — 652 citations
- Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. (2008) — 673 citations